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Clostridium difficile is primarily recognised as a nosocomially acquired pathogen manifesting in gastrointestinal
disease subsequent to the patient receiving broad-spectrum antibiotics. Infection can be sporadic, but
outbreaks commonly occur within a ward or hospital as a result of cross-infection. Since the 1980s, the
epidemiology of C. difficile disease has been studied by the application of many different typing or
fingerprinting methods; these, and the lessons learned, are reviewed herein.
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PHENOT YPIC T YP ING METHODS
Early methods of typing Clostridium difficile were, of necessity,
based on phenotypic properties such as antibiograms. In one of
the first documented outbreak investigations, Burdon et al. [1]
found a common resistance pattern to three antibiotics in
isolates from cases on a surgical ward that were distinct from
isolates in the rest of the hospital. However, this approach is at
best only rudimentary, and a more detailed approach was tried
by Wu¨st et al. [2] who combined plasmid analysis, soluble
protein polyacrylamide gel electrophoresis (PAGE), immunoe-
lectrophoresis of extracellular antigens and antibiograms to 16
isolates from related cases of C. difficile infection. Using these
methods they showed that 12 of the 16 strains were indistin-
guishable, providing strong evidence that cross-infection had
taken place. Sell et al. [3] used a combination of bacteriocin and
bacteriophage typing methods, with a high percentage of strains
being non-typeable. Immuno-chemical fingerprinting of
EDTA-treated cell extracts of C. difficile was evaluated [4],
and Nakamura et al. [5] were the first investigators to use serum
agglutination as a typing method by raising three antisera against
C. difficile. This method could differentiate four distinct serovars
among 79 isolates from healthy carriers. Delme´e’s group [6]
improved this method and developed a serotyping scheme that
could recognise 19 distinct sero-groups. This method is fre-
quently used as the standard by which other typing methods are
compared.
These early typing methods were ostensibly developed to
understand the epidemiology of C. difficile infection at a local
level. Many of these investigations found evidence that a single
type was responsible for a number of cases within their hospital,
thus confirming that C. difficile disease could be a cross-infection
problem. It soon became apparent, however, that whilst these
methods were adequate for local use, there was a need for typing
schemes that could be applied to further our understanding of
the epidemiology of C. difficile disease on a wider scale. To
facilitate this, comparisons between typing schemes were per-
formed, and Mulligan et al. [7] found good correlation between
the types recognised by plasmid profiling, serotyping, PAGE of
cell surface antigens and immunoblotting. Sodium dodecyl
sulfate (SDS)-PAGE of whole-cell proteins was applied to
79 isolates in an outbreak investigation and this method yielded
a maximum of approximately 40 bands ranging in size from 18
to 100 kilo-daltons (kDa). This investigation showed 60 of
the 79 isolates to be indistinguishable. SDS-PAGE of EDTA-
extracted cell surface antigens was compared to serogrouping by
Ogunsola et al. [8], analysing 61 isolates. This method yielded
bands of between 30 and 67 kDa and split their 79 isolates into
17 groups, which generally correlated well with the results of
serogrouping, and could in fact, differentiate between some
members of the same serogroup. The whole-cell fingerprinting
method of pyrolysis mass spectrometry (PMS) has been success-
fully used as a means of investigating putative C. difficile out-
breaks [9]. This method has the advantage that it can cope with a
large throughput of strains and has a high degree of discrimina-
tion. Its disadvantages, however, are the initial cost of the
equipment and its inability to assign a permanent type to a
strain.
MOLECULAR T YP ING METHODS
Molecular typing methods are generally regarded as superior to
phenotypic methods in terms of the stability of marker expres-
sion and providing greater levels of typeability, and a number of
molecular methods have been applied to C. difficile. Plasmid
profiling proved largely unsuccessful due to the sparse distribu-
tion of these extra-chromosomal genetic elements within the
species. However, analysis of chromosomal DNA of C. difficile
was tried by Kuijper et al. [10] who used whole cell DNA
restriction endonuclease analysis (REA) using HindIII in an
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investigation which demonstrated cross-infection between two
patients in the same room. REA is a highly discriminatory and
reproducible method; it is, however, a technically demanding
procedure and is very labor-intensive, especially for large
numbers of isolates. Restriction fragment length polymorphism
(RFLP) is an alternative genotypic method that involves initial
REA digestion followed by gel electrophoresis and Southern
blotting with selected labeled nucleic acid probes to highlight
specific restriction site heterogeneity. RFLP, however, is also a
very labor-intensive method and REA/RFLP methods have
generally been superseded by methods based on the polymerase
chain reaction (PCR).
Arbitrarily primed PCR (AP-PCR) is a genotypic method
that permits the detection of polymorphisms within the target
genome without prior knowledge of the target nucleotide
sequence. A closely related method called random amplified
polymorphic DNA (RAPD) commonly uses two oligonucleo-
tide primers which are short in length (c.10 bp) and also of
arbitrary sequence. Barbut et al. [11] evaluated a RAPD method
using two 10-bp primers in an investigation of antiobiotic-
associated diarrhea (AAD) in AIDS patients. The same PCR
profiles were found in 25 isolates from 15 patients, suggesting
infection with the same strain.
PCR ribotyping uses specific primers complementary to sites
within the RNA operon and was first applied to C. difficile by
Gurtler [12] who targeted the amplification process at the spacer
region between the 16S and 23S rRNA regions. C. difficile was
shown to possess multiple copies of the rRNA genes, which not
only varied in number between strains but also in size between
different copies on the same genome. This approach was
simplified by Cartwright et al. [13] who applied it to 102
isolates obtained from 73 symptomatic patients. Using the same
primers as Gurtler, their PCR fragments of similar size range
could be separated by straightforward agarose gel electrophor-
esis instead of denaturing PAGE gels. Furthermore, they
demonstrated that the banding patterns were not affected by
the quantity of DNA used in the reaction (a problem associated
with AP-PCR and RAPD methods), and that the PCR
ribotype marker was stable and its expression reproducible.
This approach was adapted for routine use by O’Neill et al.
[14] who improved the methodology even more by greatly
simplifying the DNA extraction method. Using modified
primers to the 16S23S spacer region, this method produced
amplicons ranging from 250 to 600 bp in length that could be
separated by straightforward agarose gel electrophoresis. The
discriminatory power was compared to Delme´e’s serogroups
and gave different banding patterns for each of the 19 ser-
ogroups. This method has been used routinely by the UK
Anaerobe Reference Unit in Cardiff, which has provided a C.
difficile typing service for the UK since 1995. From over 3000
strains from all sources examined, a library consisting of 116
distinct ribotypes has been constructed [15] (Figure 1).
Pulsed field gel electrophoresis (PFGE) allows the whole
genome to be analyzed after digestion with rare cutting restric-
tion endonucleases, such as SmaI, KspI, SacII or NruI, which
produce up to 10 fragment length polymorphisms per strain.
PFGE has been applied successfully to many different genera
and was used to investigate 22 isolates of C. difficile from an
outbreak in an elderly care facility and 30 epidemiologically
unrelated isolates [16]. PCR ribotyping was deemed more
discriminatory than AP-PCR and PFGE methods in a study
[17]. The authors also highlighted the lack of reproducibility of
AP-PCR methods, as discrepancies were noted using the same
primers in different laboratories. Whilst PFGE is very discri-
minatory, disadvantages include the initial cost of the equip-
ment, the slowness of the electrophoresis procedure and its
complexity. Bidet et al. [18] compared all three methods and
concluded that PCR ribotyping, although marginally less dis-
criminatory than PFGE, offered the best combination of
advantages. Spigaglia et al. [19] also found good correlation
between PFGE and PCR riboyping, but experienced eight
isolates that were non-typeable by PFGE. Many workers have
also noted that some strains are repeatedly untypeable by PFGE
due to degradation of the extracted DNA. Studies have shown
that these PFGE-untypeable strains belong to serogroup G,
which corresponds to PCR ribotype 1 in the library of Stubbs
et al. [15]. The toxinotyping method developed by Rupnik
described 11 toxinotypes and has been compared to PCR
ribotyping [20]. Good correlation between the methods was
noted and, whilst applying toxinotyping to each type in the
PCR ribotype library, five novel toxinotypes were discovered
and given ribotypes that had consistent changes in their toxin
genes. A recently described alternative PCR target for typing
purposes was the flagellin gene flicC, described by Tasteyre et al.
[21]; flicC could discriminate nine different RFLP patterns in a
study of 47 isolates.
All typing methods have certain advantages and disadvan-
tages, but their ultimate contribution to knowledge is dictat-
ed by their performance according to the criteria listed by
Struelens; namely, typeability, reproducibility, stability, discri-
minatory power and epidemiological concordance [22]. It
Figure1 PCR ribotyping gel ofC. difficile strains (lanes1, 6,11and16,100bp
interval ladders).
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should also have technical advantages such as ease of perfor-
mance, relative low cost and high throughput. In due course, as
new methods come and go, one method will probably emerge
as being the most suitable.
CONTRIBUTIONS TO KNOWLEDGE BY
C. DIFFICILE T YP ING STUDIES
Since typing methods were applied to C. difficile, a picture of our
understanding of the epidemiology of C. difficile disease on
national and international scales has begun to emerge. An
international typing study [23] involving seven groups of work-
ers from the UK, Belgium, Australia and the USA was set up
and participants were asked to submit their type strains as
delineated by their own methods, which included radio-PAGE,
immunoblotting, REA, serogrouping, RFLP, PCR ribotyping
and AP-PCR. These were checked, blind coded and, together
with some wild-type isolates, 100 strains were distributed to
each group. Each group typed the set by their own method and
submitted their results back to the study coordinator. The
preliminary findings of the study were revealing. Many of
the groups encountered new strains not previously recognised
by their own typing methods, suggesting that there are more
types of C. difficile in existence than was previously appreciated
by each group acting individually. There was complete correla-
tion between the results of the three typing schemes that were
based either directly or indirectly on cell surface proteins. This
study also revealed that certain types were common to each
typing method, indicating distribution of the same types in
hospitals in the UK, Belgium, USA and Australia.
Relatively little is known about the national distribution of
strains of C. difficile circulating the hospitals in individual
countries. Probably the most comprehensive national surveil-
lance data have come from the UK Anaerobe Reference Unit in
Cardiff, where over 2000 patient stool isolates submitted from
58 UK hospitals have yielded some interesting statistics. In total,
54 different PCR ribotypes have been identified from hospital
patients, but just 16 types make up 90% of all referrals, and one
particular PCR ribotype, Type 1, accounts for 58% of the total
of all hospital patient isolates. The next most common strain,
PCR ribotype 106, accounts for just 7%, although this strain has
spread from its origins in the midlands to London and the
southeast of England in the last few years. PCR Type 1 appears
to be endemic in almost all of the hospitals surveyed and is
associated with both acute and prolonged outbreaks. It was
PCR Type 1 that was responsible for the most publicised
outbreak in the UK involving 175 patients and 17 deaths in
a hospital in the northwest of England [24]. On an international
scale, Brazier’s study [23] revealed that PCRType 1 corresponds
to Delme´e’s serogroup G, and this strain is also causing problems
in the USA. PCR Type 1 was found to be the same as strain D1
described by Samore et al. [25], who found this was the most
common strain isolated from environmental sources, personnel
hand carriage and symptomatic patients in an American East
Coast tertiary referral hospital. This same type has also pre-
dominated in a series of 59 isolates from elderly male patients in
a hospital in California (M. E. Mulligan, personal communica-
tion). Research is currently underway in Cardiff applying the
whole genome typing method, amplified fragment length
polymorphism (AFLP), to C. difficile PCR ribotype 1, to
determine if it can be subtyped. The prevalence of this strain
in the UK is in contrast to findings in some other European
countries. Delme´e’s group reported that serogroup C was most
commonly implicated in outbreaks in Belgium [26]. This
serogroup corresponds to PCR Type 12, which accounts for
only 2.6% of typed hospital isolates in England and Wales. A
multicentre study of 11 hospitals in France [27] found ser-
ogroups C, D, G and H were the most common strains, with
serogroup H predominant (accounting for 21%), and that
serogroup C was most often associated with antibiotic treatment
and diarrhea. While most studies have shown that a cluster of
cases of C. difficile infection was due to a single strain, others
have demonstrated that clusters of cases have been due to
unrelated strains. These sporadic cases demonstrate that not
all cases of C. difficile infection are due to cross-infection and
most probably represent the diverse strains brought in from the
community.
It is also known that serogroup F produces toxin B but not
toxin A, and corresponds mainly to PCR Type 17. Data from
strains received for typing in England and Wales indicate that
toxin A-negative/B-positive strains have been detected in 10
UK hospitals [28]. They account for just under 3% of the total
hospital isolates examined; although in one particular hospital
they accounted for 10% of the total isolates submitted for
typing. It is possible that these strains are not being detected
because of the common use of diagnostic kits that detect toxin A
only, and therefore it may be far more prevalent than we
currently appreciate.
Strains originating from General Practice patients and con-
trols in England show a different distribution of PCR ribotypes
compared to those found in English hospital patients. The most
predominant strain in a community-based study that yielded
390 isolates was PCR Type 10, which is non-toxigenic and
accounted for 15.9% of isolates. PCR Type 1, which accounts
for 58% of the hospital patient isolates, made up only 7.4% of
the community patient isolates. Compared to the overwhelm-
ing predominance of one strain in UK hospitals, the profile of
types in the community was far more even, with PCR ribotypes
10, 20 and 14 the most common, accounting for 15.9%, 11.8%
and 8.7%, respectively. This indicates that certain strains seem to
proliferate in hospitals and may even be selected for by local
environmental pressures in the hospital ward.
The recently formed ESCMID Study Group on Clostridium
difficile (ESGCD) has been established to focus on the problem
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of C. difficile infection from a European perspective. No doubt
this, and other typing studies of C. difficile, will play a key role in
our ongoing attempts to understand the global epidemiology of
this nosocomial pathogen and its associated disease.
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